ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Case Report

Case Report: Chorea an unusual presentation of a patient with clinically isolated syndrome (multiple sclerosis)

[version 1; peer review: 1 approved with reservations, 1 not approved]
PUBLISHED 11 Oct 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Neuroinflammation collection.

Abstract

This is a case report of a 26 year old girl who presented with choreiform movements of the upper and lower limbs and generalised tonic clonic seizures who had an entity called clinically isolated syndrome of multiple sclerosis on investigation. The pooled incidence rate in 75 reporting countries was 2.1 per 100,000 persons/year, with 32 years of age being the mean age of diagnosis. But multiple sclerosis is a white matter disease and choreiform movements are due to involvement of the grey matter of the brain. There have only been a few case reports of patients with multiple sclerosis having choreoathetoid movements reported.

Keywords

Multiple sclerosis, clinically isolated syndrome, chorea, gray matter involvement

Introduction

Multiple Sclerosis is a chronic disabling immune mediated inflammatory disease that affects the brain and the spinal cord.1 Our patient presented with her first central nervous system demyelinating event which is known as clinically isolated syndrome which is a presentation that has features like multiple sclerosis but is isolated in time may or may not be isolated in space.4

Case report

Our patient was a 26-year-old university student studying arts in Jaffna who presented with choreiform movements of her upper and lower limbs of two months in duration. The movements affected her day-to-day activities and made her quite dependant on others. She had also developed two episodes of generalised tonic clonic seizures of 15 minutes duration one hour apart. There was no history of early morning headache or vomiting or upper and lower limb weakness. The patient had not developed any form of neurological weakness. There was a history of febrile illness and sore throat two weeks prior to the onset. During her illness she did not notice any joint pain or swelling or any rashes. There was no history of jaundice. She was not on any long term medications neither had she taken any medication both allopathic or ayruvedic recently. The patient did not use any recreational drugs, did not consume alcohol or use an ayruvedic medication. There was no history of psychiatric illness in her or her family. Patient was not on any oral contraceptives neither was she sexually active. There was no family history of neurological disease. There had been no antenatal or perinatal insult during her birth and her vaccination was up to date. She also developed a few episodes of generalised tonic clonic seizures lasting about 5 minutes each before and after admission.

Her examination findings were, she was conscious rational with a Glasgow coma score of 15/15. Her general exam did not reveal any icterus or rash, no stigmata of infective endocarditis. The respiratory, abdominal, and cardiovascular system examination were normal. In her neurological exam. On examination of both her fundus no papilledema was noted or no optic atrophy seen in both eyes. Swallowing was intact, her tongue had fasciculations and a jack in the box appearance. Motor examination revealed normal power and tone however she had abnormal movements more in the distal limb than in the proximal limbs. In the cerebellar exam she was not able to perform the finger nose test, heel shin she had dysdiadochokinesia in the left hand and the right hand and also the heel shin test was positive. Romberg's was positive and tandem gait was unstable. Deep tendon reflexes were +2 and symmetrical in the arms, the ankles and at the knees. Her plantar reflexes on both legs were down going. Pin prick, light touch and proprioception were normal. Romberg's was positive and tandem gait was unstable.

We had a few differential diagnoses in mind while investigating her mostly along the lines of diseases causing chorea in a young females such as Vasculitis, Wilsons disease, Hungtintons, hyperthyroidism. Eye referral done no Kayser Flecher rings were noted which is one of the eye signs noted in Wilson’s disease and as show below serum ceruloplasmin was normal which ruled out Wilson’s disease.

BLOOD INVESTIGATIONS

Full blood count

hemoglobin8.3g/dl (12.00-15.00)
White blood cells7.99 x 10 9 (4-10.00)
neutrophils92% (40-80)
Plaletets533 (150-400)

Erythrocyte Sedimentation rate (ESR)=25mm

Renal function Test

Na+139mmol/L (136-145)
K+3.7mmol/L (3.5-5.1)
Serum Cr54mg/dl
GFR126.16

Liver function test

AST13 U/L (16-63)
ALT9 U/L (15-37)
ALP61 U/L (46-116)
GGT17 U/L (5-40)
Total bilirubin7.7mmol/L (0-17)
Direct Billirubin1.7mmolL (0-8)
Total Protein73g/L (64-82)
Albumin40g/L (34-50)

Serology

HIV 1 and 2 ELISA=negative,

VDRL= non reactive,

Mycoplasma pneumonia antibody Ig G and IgM=insignificant titres

Immmology

Antinuclear antibody=negative,

Serum ceruloplasmin level=313mg/dl

TSH=1.4 mIU/L(0.4-4)

Antistreptolysin O titre = <200U/L

Blood picture Microcytic, hypochromic red pencil cell, few acanthocytes, no evidence of acanthocytosis mild neutrophilic leukocytosis could be due to an inflammatory process.

EEG(electroencephalogram) = Asymmetrical focal changes and slow waves

CSF (cerebrospinal fluid) report

CSF full report= normal and CSF culture = no growth

CSF = no oligocloncal bands

CSF Cytomegalovirus PCR = negative

CSF Herpes simplex virus 1 and 2 PCR =negative

Imaging

Ultrasound abdomen= normal.

2DEcho=Normal no vegetations no valvular lesions

CT Brain: Multiple periventricular hypodensity? White matter disease

Visual evoked potentials = Markedly delayed bilaterally assuming there is no refractory error. The findings indicate demyelinating pathology affecting the visual pathway

The CT brain gave us a clue to the diagnosis and MRI and visual evoked potentials confirmed the diagnosis. Patient was given a course of methylprednisolone of 1g daily for three days and then started on prednisolone which was tailed off. Sodium Valproate 200 mg TDS and levecitracetum500mg daily was added for her seizures (Figure 1).

5506b580-82f9-4597-a685-836c71f013aa_figure1.gif

Figure 1. MRI Brain.

Peritrigonal centrum semiovale subcortical white matter signal intensity change. No contrast enhancement or diffusion restriction to suggest active lesions. Appearances are of white matter changes of Multiple Sclerosis.

Discussion

Multiple Sclerosis is a disabling disease affecting the brain and the spinal cord.2 According to the National Multiple Sclerosis Society there are four subtype definitions Relapsing and remitting, secondary progressive, primary progressive and progressive relapsing other subtypes however have been identified. Clinically isolated syndrome is one such subtype.3 Clinical isolated syndrome refers to the first CNS demyelinating event that has features similar to Multiple sclerosis but is isolated in time may or may not be isolated in space.4

There are 5 different types of clinically isolated syndrome:

Type 1 which is clinically monofocal with atleast one asymptomatic lesion. Type 2 is clinically multifocal in nature with atleast one asymptomatic lesion. MRI lesion. Type 3 is clinically monofocal MRI may appear normal no asymptomatic MRI lesions. Type 4 clinically multifocal MRI may appear normal no asymptomatic MRI lesions Type 5 no clinical presentation to suggest demyelinating disease, but MRI is suggestive. The term clinically isolated syndrome ignores presentations that may be found only on laboratory data and paraclinical findings. Although a kind of exception to this is CIS type 5 where patients have nonspecific symptoms such as headache and dizziness but have MRI evidence of multifocal abnormalities of demyelination.5

Some of the clinical presentations of CIS include optic neuritis, a brain stem and or cerebellar syndrome, a spinal cord syndrome, or occasionally cerebral hemispheric dysfunction. We should also probe about whether the patient had some neurological weakness in the past, any blurring of vision, L hermitte sign, numbness or neurological weakness lasting about more than 24 hours. Questions about infections, inflammatory disorders, metabolic, genetic disorders, vascular and autoimmune diseases should also be sought.6

Chorea is rather an unusual manifestation of multiple sclerosis because multiple sclerosis is thought to be a white matter disease however there is evidence to prove now that it can involve both the cortical and sub cortical gray matter and the latter has myelinated fibers which may explain the involvement of the striatum, pallidum, thalamus and brainstem in multiple sclerosis.10 Usually multiple sclerosis patients may present with a tremor but movement disorders are less frequently reported.8 Giada Giovanni et al have reported on a case of hemichorea in a 39 year old women who had MRI evidence of multiple sclerosis and the CSF was positive for oligoclonal bands.9 Our patient presented to us with choreiform movements and she was diagnosed of having clinically isolated syndrome because of the lack of previous episodes of neurological presentations. There was sufficient evidence in her MRI; the lesions were suggestive of multiple sclerosis and her visually evoked potential showed marked delaying bilaterally indicating demyelinating pathology. In our patient oligo clonal bands were negative and in a study done by Jaganndha R et al showed that absence of oligo clonal bands is associated with a better prognosis in multiple sclerosis.10

Usually episodes of multiple sclerosis are mild and resolve without medication, severe visual loss, pain in optic neuritis, pronounced motor dysfunction, ataxia, vertigo in spinal or brainstem syndromes are some of the symptoms that indicate that treatment is needed. Corticosteriods are used when symptoms are functionally disabling as in our case. A combination of intravenous methylprednisolone and oral steroids have be noted to lower the risk of developing clinically definite multiple sclerosis in the following two years.7

Multiple sclerosis can manifest in different ways and although it is predominantly a white matter disease it can affect the subcortical gray matter explaining the presentation of chorea in this young lady.

Consent

Written informed consent for the publication of the case report and any associated images was sought from the patient prior to submission.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 11 Oct 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
suraweera r, Uthayakumaran S and Kamala J. Case Report: Chorea an unusual presentation of a patient with clinically isolated syndrome (multiple sclerosis) [version 1; peer review: 1 approved with reservations, 1 not approved]. F1000Research 2023, 12:1301 (https://doi.org/10.12688/f1000research.140610.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 11 Oct 2023
Views
3
Cite
Reviewer Report 03 May 2024
Keshinie Samarasekara, Department of Acute Medicine, Royal Liverpool Univeristy Hospital, Colombo, UK 
Not Approved
VIEWS 3
The authors have described a case of a young female presenting with chorea and generalised tonic clonic seizures, as an unusual presentation of multiple sclerosis.
Both chorea and generalised tonic clonic seizures are extremely rare in multiple sclerosis(MS), with ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Samarasekara K. Reviewer Report For: Case Report: Chorea an unusual presentation of a patient with clinically isolated syndrome (multiple sclerosis) [version 1; peer review: 1 approved with reservations, 1 not approved]. F1000Research 2023, 12:1301 (https://doi.org/10.5256/f1000research.153982.r257538)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
11
Cite
Reviewer Report 18 Dec 2023
Harsha Dissanayake, University of Colombo, Colombo, Sri Lanka 
Approved with Reservations
VIEWS 11
Peer review

Case Report: Chorea an unusual presentation of a patient with clinically isolated syndrome (multiple sclerosis)

Suraweera and colleagues report a case of a young Sri Lankan female who was diagnosed with ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Dissanayake H. Reviewer Report For: Case Report: Chorea an unusual presentation of a patient with clinically isolated syndrome (multiple sclerosis) [version 1; peer review: 1 approved with reservations, 1 not approved]. F1000Research 2023, 12:1301 (https://doi.org/10.5256/f1000research.153982.r223055)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 17 Jan 2024
    rasangi suraweera, critical care, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, Gl3 4NN, UK
    17 Jan 2024
    Author Response
    The pooled incidence rate in 75 reporting countries was 2.1 per 100,000 persons/year, with 32 years of age being the mean age of diagnosis.’ This is the incidence of MS ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 17 Jan 2024
    rasangi suraweera, critical care, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, Gl3 4NN, UK
    17 Jan 2024
    Author Response
    The pooled incidence rate in 75 reporting countries was 2.1 per 100,000 persons/year, with 32 years of age being the mean age of diagnosis.’ This is the incidence of MS ... Continue reading

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 11 Oct 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.